BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23096769)

  • 1. Cognitive effects of intramuscular ketamine and oral triazolam in healthy volunteers.
    Carter LP; Kleykamp BA; Griffiths RR; Mintzer MZ
    Psychopharmacology (Berl); 2013 Mar; 226(1):53-63. PubMed ID: 23096769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive, psychomotor, and subjective effects of sodium oxybate and triazolam in healthy volunteers.
    Carter LP; Griffiths RR; Mintzer MZ
    Psychopharmacology (Berl); 2009 Sep; 206(1):141-54. PubMed ID: 19543883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive and subjective acute dose effects of intramuscular ketamine in healthy adults.
    Lofwall MR; Griffiths RR; Mintzer MZ
    Exp Clin Psychopharmacol; 2006 Nov; 14(4):439-49. PubMed ID: 17115871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose effects of triazolam and alcohol on cognitive performance in healthy volunteers.
    Kleykamp BA; Griffiths RR; Mintzer MZ
    Exp Clin Psychopharmacol; 2010 Feb; 18(1):1-16. PubMed ID: 20158290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute cognitive effects of high doses of dextromethorphan relative to triazolam in humans.
    Carter LP; Reissig CJ; Johnson MW; Klinedinst MA; Griffiths RR; Mintzer MZ
    Drug Alcohol Depend; 2013 Mar; 128(3):206-13. PubMed ID: 22989498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triazolam and zolpidem: a comparison of their psychomotor, cognitive, and subjective effects in healthy volunteers.
    Mintzer MZ; Frey JM; Yingling JE; Griffiths RR
    Behav Pharmacol; 1997 Nov; 8(6-7):561-74. PubMed ID: 9832970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to, "Cognitive, psychomotor and subjective effects of sodium oxybate and triazolam in healthy volunteers," 2009; 206(1):141-154.
    Zvosec DL; Smith SW
    Psychopharmacology (Berl); 2009 Dec; 207(3):509-10; author reply 511-2. PubMed ID: 19777215
    [No Abstract]   [Full Text] [Related]  

  • 8. Triazolam-amphetamine interaction: dissociation of effects on memory versus arousal.
    Mintzer MZ; Griffiths RR
    J Psychopharmacol; 2003 Mar; 17(1):17-29. PubMed ID: 12680736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative cognitive and psychomotor effects of single doses of Valeriana officianalis and triazolam in healthy volunteers.
    Hallam KT; Olver JS; McGrath C; Norman TR
    Hum Psychopharmacol; 2003 Dec; 18(8):619-25. PubMed ID: 14696021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.
    Johnson MW; Suess PE; Griffiths RR
    Arch Gen Psychiatry; 2006 Oct; 63(10):1149-57. PubMed ID: 17015817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative abuse liability of GHB in humans: A comparison of psychomotor, subjective, and cognitive effects of supratherapeutic doses of triazolam, pentobarbital, and GHB.
    Carter LP; Richards BD; Mintzer MZ; Griffiths RR
    Neuropsychopharmacology; 2006 Nov; 31(11):2537-51. PubMed ID: 16880774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A triazolam/amphetamine dose-effect interaction study: dissociation of effects on memory versus arousal.
    Mintzer MZ; Griffiths RR
    Psychopharmacology (Berl); 2007 Jun; 192(3):425-40. PubMed ID: 17342474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the acute behavioral effects of triazolam and temazepam in normal volunteers.
    Rush CR; Higgins ST; Hughes JR; Bickel WK
    Psychopharmacology (Berl); 1993; 112(4):407-14. PubMed ID: 7871050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ketamine on psychomotor, sensory and cognitive functions relevant for driving ability.
    Giorgetti R; Marcotulli D; Tagliabracci A; Schifano F
    Forensic Sci Int; 2015 Jul; 252():127-42. PubMed ID: 25981945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose effects of triazolam and scopolamine on metamemory.
    Mintzer MZ; Kleykamp BA; Griffiths RR
    Exp Clin Psychopharmacol; 2010 Feb; 18(1):17-31. PubMed ID: 20158291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of acute treatment with ramelteon, triazolam, and placebo on driving performance, cognitive function, and equilibrium function in healthy volunteers.
    Miyata A; Iwamoto K; Kawano N; Kohmura K; Yamamoto M; Aleksic B; Ebe K; Noda A; Noda Y; Iritani S; Ozaki N
    Psychopharmacology (Berl); 2015 Jun; 232(12):2127-37. PubMed ID: 25533998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is atropine needed with ketamine sedation? A prospective, randomised, double blind study.
    Heinz P; Geelhoed GC; Wee C; Pascoe EM
    Emerg Med J; 2006 Mar; 23(3):206-9. PubMed ID: 16498158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability.
    Evans SM; Funderburk FR; Griffiths RR
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1246-55. PubMed ID: 2262904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative abuse liability of indiplon and triazolam in humans: a comparison of psychomotor, subjective, and cognitive effects.
    Carter LP; Griffiths RR; Suess PE; Casada JH; Wallace CL; Roache JD
    J Pharmacol Exp Ther; 2007 Aug; 322(2):749-59. PubMed ID: 17502431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketamine anesthesia during the first week of life can cause long-lasting cognitive deficits in rhesus monkeys.
    Paule MG; Li M; Allen RR; Liu F; Zou X; Hotchkiss C; Hanig JP; Patterson TA; Slikker W; Wang C
    Neurotoxicol Teratol; 2011; 33(2):220-30. PubMed ID: 21241795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.